Isolevuglandins Promote Mitochondrial Dysfunction and Electrophysiologic Abnormalities in Atrial Cardiomyocytes
Cells · 2024
DOI: 10.3390/cells13060483 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Tuerdi Subati und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Mitochondrial Diseases, Benzylamines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIDDK NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, yet the cellular and molecular mechanisms underlying the AF substrate remain unclear. Isolevuglandins (IsoLGs) are highly reactive lipid dicarbonyl products that mediate oxidative stress-related injury. In murine hypertension, the lipid dicarbonyl scavenger 2-hydroxybenzylamine (2-HOBA) reduced IsoLGs and AF susceptibility. We hypothesized that IsoLGs mediate detrimental pathophysiologic effects in atrial cardiomyocytes that promote the AF substrate. Using Seahorse XFp extracellular flux analysis and a luminescence assay, IsoLG exposure suppressed intracellular ATP production in atrial HL-1 cardiomyocytes. IsoLGs caused mitochondrial dysfunction, with reduced mitochondrial membrane potential, increased mitochondrial reactive oxygen species (ROS) with protein carbonylation, and mitochondrial DNA damage. Moreover, they generated cytosolic preamyloid oligomers previously shown to cause similar detrimental effects in atrial cells. In mouse atrial and HL-1 cells, patch clamp experiments demonstrated that IsoLGs rapidly altered action potentials (AP), implying a direct effect independent of oligomer formation by reducing the maximum Phase 0 upstroke slope and shortening AP duration due to ionic current modifications. IsoLG-mediated mitochondrial and electrophysiologic abnormalities were blunted or totally prevented by 2-HOBA. These findings identify IsoLGs as novel mediators of oxidative stress-dependent atrial pathophysiology and support the investigation of dicarbonyl scavengers as a novel therapeutic approach to prevent AF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
- Division of Clinical Pharmacology Room 559, Preston Research Building, Vanderbilt University School of Medicine, 2220 Pierce Avenue, Nashville, TN 37232, USA.
ORCID-Profile: Zhenjiang Yang, David Z Trykall
Förderung
- NIH HHS
- NIDDK NIH HHS
- NHLBI NIH HHS
- NCI NIH HHS
- NEI NIH HHS
- National Heart, Lung, and Blood Institute at the National Institutes of Health
- American Heart Association
- NIH
Zitieren
APA
Subati, T., Yang, Z., Murphy, M. B., Stark, J. M., Trykall, D. Z., Davies, S. S., Barnett, J. V., & Murray, K. T. (2024). Isolevuglandins Promote Mitochondrial Dysfunction and Electrophysiologic Abnormalities in Atrial Cardiomyocytes. Cells. https://doi.org/10.3390/cells13060483
Vancouver
Subati T, Yang Z, Murphy MB, Stark JM, Trykall DZ, Davies SS, et al. Isolevuglandins Promote Mitochondrial Dysfunction and Electrophysiologic Abnormalities in Atrial Cardiomyocytes. Cells. 2024. doi:10.3390/cells13060483
BibTeX
@article{Subati2024,
author = {Subati, Tuerdi and Yang, Zhenjiang and Murphy, Matthew B and Stark, Joshua M and Trykall, David Z and Davies, Sean S and Barnett, Joey V and Murray, Katherine T},
title = {Isolevuglandins Promote Mitochondrial Dysfunction and Electrophysiologic Abnormalities in Atrial Cardiomyocytes},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13060483}
}
EUVIMED